Cardlytics Inc (NASDAQ: CDLX) is -14.82% lower on its value in year-to-date trading and has touched a low of $2.76 and a high of $20.52 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CDLX stock was last observed hovering at around $3.06 in the last trading session, with the day’s gains setting it 0.1%.
Currently trading at $3.16, the stock is -9.03% and -16.02% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.92 million and changing 3.27% at the moment leaves the stock -50.97% off its SMA200. CDLX registered -50.93% loss for a year compared to 6-month loss of -62.47%. The firm has a 50-day simple moving average (SMA 50) of $3.7629 and a 200-day simple moving average (SMA200) of $6.444825.
The stock witnessed a -16.18% gain in the last 1 month and extending the period to 3 months gives it a -17.71%, and is 0.96% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.51% over the week and 7.82% over the month.
Cardlytics Inc (CDLX) has around 434 employees, a market worth around $160.60M and $293.47M in sales. Profit margin for the company is -93.55%. Distance from 52-week low is 14.37% and -84.60% from its 52-week high. The company has generated returns on investments over the last 12 months (-112.77%).
with sales reaching $63.45M over the same period.The EPS is expected to shrink by -10.30% this year, but quarterly earnings will post -13.35% year-over-year. Quarterly sales are estimated to shrink -28.84% in year-over-year returns.
Cardlytics Inc (CDLX) Top Institutional Holders
158.0 institutions hold shares in Cardlytics Inc (CDLX), with institutional investors hold 63.24% of the company’s shares. The shares outstanding are 50.34M, and float is at 48.43M with Short Float at 15.26%. Institutions hold 59.98% of the Float.
The top institutional shareholder in the company is CAS INVESTMENT PARTNERS, LLC with over 6.46 million shares valued at $53.08 million. The investor’s holdings represent 14.9483% of the CDLX Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 3.15 million shares valued at $25.88 million to account for 7.2876 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 2.41 million shares representing 5.5784% and valued at over $19.81 million, while MORGAN STANLEY holds 5.0082 of the shares totaling 2.17 million with a market value of $17.78 million.
Cardlytics Inc (CDLX) Insider Activity
The most recent transaction is an insider sale by DeSieno Alexis, the company’s Chief Financial Officer. SEC filings show that DeSieno Alexis sold 8,854 shares of the company’s common stock on Jan 03 ’25 at a price of $3.67 per share for a total of $32468.0. Following the sale, the insider now owns 0.12 million shares.
Cardlytics Inc disclosed in a document filed with the SEC on Jan 03 ’25 that Lynton Nicholas Hollmeyer (Chief Legal & Privacy Officer) sold a total of 6,464 shares of the company’s common stock. The trade occurred on Jan 03 ’25 and was made at $3.67 per share for $23703.0. Following the transaction, the insider now directly holds 91771.0 shares of the CDLX stock.
Still, SEC filings show that on Jan 03 ’25, Gupta Amit (Chief Executive Officer) disposed off 5,964 shares at an average price of $3.67 for $21870.0. The insider now directly holds 186,904 shares of Cardlytics Inc (CDLX).
